Standout Papers

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian ... 2005 2026 2012 2019 1.7k
  1. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer (2010)
    Ignace Vergote, Claes G. Tropé et al. New England Journal of Medicine
  2. Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer (2012)
    Jonathan A. Ledermann, Philipp Harter et al. New England Journal of Medicine
  3. Epithelial ovarian cancer (2019)
    Stéphanie Lheureux, Charlie Gourley et al. The Lancet
  4. Endometrial cancer (2005)
    Frédéric Amant, Philippe Moerman et al. The Lancet
  5. Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial (2014)
    Éric Pujade-Lauraine, Felix Hilpert et al. Journal of Clinical Oncology
  6. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial (2014)
    Jonathan A. Ledermann, Philipp Harter et al. The Lancet Oncology
  7. Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study (2000)
    Jacques Bonneterre, Beat Thürlimann et al. Journal of Clinical Oncology
  8. Gemcitabine Plus Carboplatin Compared With Carboplatin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer: An Intergroup Trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG (2006)
    Jacobus Pfisterer, Marie Plante et al. Journal of Clinical Oncology
  9. Sentinel Node Dissection Is Safe in the Treatment of Early-Stage Vulvar Cancer (2008)
    Ate G.J. van der Zee, Maaike H.M. Oonk et al. Journal of Clinical Oncology
  10. Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) (2011)
    Ignace Vergote, Elizabeth A. Eisenhauer et al. International Journal of Gynecological Cancer
  11. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse (2010)
    Éric Pujade-Lauraine, Uwe Wagner et al. Journal of Clinical Oncology
  12. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial (2016)
    Jonathan A. Ledermann, Philipp Harter et al. The Lancet Oncology
  13. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Journal of Clinical Oncology
  14. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Gynecologic Oncology
  15. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease (2019)
    Nicoletta Colombo, C. Sessa et al. International Journal of Gynecological Cancer
  16. Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I (2021)
    Kathleen N. Moore, Amit M. Oza et al. Annals of Oncology

Immediate Impact

3 by Nobel laureates 4 from Science/Nature 67 standout
Sub-graph 1 of 19

Citing Papers

Designing antibodies as therapeutics
2022 Standout
Endometriosis: Etiology, pathobiology, and therapeutic prospects
2021 Standout
12 intermediate papers

Works of Ignace Vergote being referenced

Clinical Outcome After Radical Excision of Moderate—Severe Endometriosis With or Without Bowel Resection and Reanastomosis
2013
Surgical treatment of deeply infiltrating endometriosis with colorectal involvement
2011
and 12 more

Author Peers

Author Last Decade Papers Cites
Ignace Vergote 20791 13074 12303 847 36.9k
Robert C. Bast 13430 13462 3993 583 44.0k
Robert L. Coleman 9133 7443 5543 657 22.5k
Bradley J. Monk 9006 8253 7806 572 22.2k
Robert A. Soslow 10108 4252 10830 422 23.0k
Michael Friedländer 9605 15324 2542 486 26.8k
Frédéric Amant 8626 6917 8392 530 21.0k
Douglas A. Levine 7181 6587 4399 253 21.8k
Karen H. Lu 8090 6678 5085 425 21.0k
Jalid Sehouli 7543 5694 3644 830 18.5k
Maurie Markman 7701 6320 2663 412 19.5k

All Works

Loading papers...

Rankless by CCL
2026